COVID-19-Associated Fungal Infections: An Urgent Need for Alternative Therapeutic Approach?
Secondary fungal infections may complicate the clinical course of patients affected by viral respiratory diseases, especially those admitted to intensive care unit. Hospitalized COVID-19 patients are at increased risk of fungal co-infections exacerbating the prognosis of disease due to misdiagnosis...
Main Authors: | Marianna Domán, Krisztián Bányai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.919501/full |
Similar Items
-
COVID-19-associated rhino-mucormycosis and pulmonary aspergillosis infection
by: Jitender Singh, et al.
Published: (2022-01-01) -
Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants
by: Obinna T. Ezeokoli, et al.
Published: (2021-07-01) -
Invasive Mixed Fungal Disease after COVID-19: A Series of Seven Cases
by: Vaishali A. Walke, et al.
Published: (2023-06-01) -
Dual Fungal Infection of Aspergillosis and Mucormycosis in a COVID-19 Patient: A Rare Case Report
by: Nikhil, et al.
Published: (2022-12-01) -
Post-COVID pulmonary fungal infections: An unanticipated predicament or a ticking time bomb? Clinico-microbiological profile of cases encountered during the second wave of COVID-19 pandemic at a teaching hospital in the Himalayas with a brief literature review
by: Oshin Puri, et al.
Published: (2023-01-01)